Movatterモバイル変換

• Home
• Editorial Board
• Submission
• Current Volume
• Archive
• Scientific Integrity
• Editorial Policies
• Publication Ethics Statements
• Special Collections
• Interviews with Outstanding Authors
• Oncotarget In The News
• Sponsored Conferences
• Search
• Contact Information

Publication Alerts

Oncoscience

Oncoscience is a peer-reviewed, open-access journal dedicated to cancer research without financial barriers. It is a unique journal that provides FREE publication and access for both authors and readers. Oncoscience is indexed and archived by PubMed and PMC. It is recognized by Impact Journals as a philanthropic endeavor.

SSP 47th Annual Meeting

Post-Publication Promotion

Impact Journals, LLC is the publisher of Oncotarget:www.impactjournals.com.

Impact Journals is a member of theWellcome Trust List of Compliant Publishers.

Impact Journals is a member of theSociety for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control.This malicious action will be reported to the FBI.

Current Volume

This Month's Popular DOIs
(Crossref resolutions)

Most popular Oncotarget DOIs, measured by the number of times each DOI was successfully resolved.

Most Popular DOIs Published in 2024
(Crossref Data)

Top-10 Most Popular DOIs of 2024
(Crossref Data)

Milestones in Modern Scholarly Publishing

• Editorial
• Editorial: Immunology
• Reviews
• Priority Research Papers
• Research Papers: Immunology
• Research Papers

About The Cover

See Tseng et al. Bisphosphonate-induced differential modulation of immune cell function in gingiva and bone marrowin vivo; Role in osteoclast-mediated NK cell activation

Table of Contents

Targeting splenic hematopoietic stem cells in cardiovascular disease

The host cell side of latent HIV-1 infection

Platelet signaling - blood’s great balancing act

Gamma-carboxylation regulates osteocalcin function

Arcuate nucleus glucokinase and dietary glucose intake

A new “sweet” ligand for Toll-like receptor 4

Deciphering the biology of NKG2C+ Natural Killer cells

NK cells in asthma exacerbation

Immunodeficiency and CARD-BCL10-MALT1

GP96: safeguarding Treg

The ‘inflammatory’ control of hematopoietic stem cells

dsRNA in immunometabolism

Notch, metabolism and macrophages

Basal body docking in airway ciliated cells

CX3CR1 in multiple sclerosis

BTK: sensing pathogenic nucleic acids

NLRP12 in autoimmune diseases

Sox5 and Th17 cell differentiation

Sec61 in antigen cross-presentation

Treg: tolerance vs immunity

Effector Tregs: middle-men in TGFβ activation

IFN type III:in vivo NK cell response

Microbial control of intestinal innate immunity

iCD8α cells: living at the edge of the intestinal immune system

Self-control for IgE production

Reactivating p53 functions by suppressing its novel inhibitor iASPP: a potential therapeutic opportunity in p53 wild-type tumors

Going viral: a review of replication-selective oncolytic adenoviruses

Loss of p53 enhances the function of the endoplasmic reticulum through activation of the IRE1α/XBP1 pathway

Bisphosphonate-induced differential modulation of immune cell function in gingiva and bone marrowin vivo: Role in osteoclast-mediated NK cell activation

Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP

A novel human STAT3 mutation presents with autoimmunity involving Th17 hyperactivation

Survivin co-ordinates formation of follicular T-cells acting in synergy with Bcl-6

CD80-CD28 signaling controls the progression of inflammatory colorectal carcinogenesis

MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer

A small-molecule inhibitor suppresses the tumor-associated mitochondrial NAD(P)+-dependent malic enzyme (ME2) and induces cellular senescence

Clinical next generation sequencing to identify actionable aberrations in a phase I program

Tanshinones suppress AURKA through up-regulation of miR-32 expression in non-small cell lung cancer

A novel SAHA-bendamustine hybrid induces apoptosis of leukemia cells

Combined targeting of EGFR/HER promotes anti-tumor efficacy in subsets of KRAS mutant lung cancer resistant to single EGFR blockade

In vivo RNAi screen identifies NLK as a negative regulator of mesenchymal activity in glioblastoma

Genomic characterization of a large panel of patient-derived hepatocellular carcinoma xenograft tumor models for preclinical development

The 14-3-3σ/GSK3β/β-catenin/ZEB1 regulatory loop modulates chemo-sensitivity in human tongue cancer

Overexpression of MAPK15 in gastric cancer is associated with copy number gain and contributes to the stability of c-Jun

High CD204⁺ tumor-infiltrating macrophage density predicts a poor prognosis in patients with urothelial cell carcinoma of the bladder

FGFR2 is overexpressed in myxoid liposarcoma and inhibition of FGFR signaling impairs tumor growthin vitro

Efficacy of the polo-like kinase inhibitor rigosertib, alone or in combination with abelson tyrosine kinase inhibitors, against break point cluster region-c-Abelson-positive leukemia cells

Enhanced antitumor efficacy of ultrasonic cavitation with up-sized microbubbles in pancreatic cancer

BCL6B expression in hepatocellular carcinoma and its efficacy in the inhibition of liver damage and fibrogenesis

Mechanism for enhanced 5-aminolevulinic acid fluorescence in isocitrate dehydrogenase 1 mutant malignant gliomas

Detecting cell-in-cell structures in human tumor samples by E-cadherin/CD68/CD45 triple staining

Hypoxia attenuates the proinflammatory response in colon cancer cells by regulating IκB

The IgH 3’ regulatory region influences lymphomagenesis in Igλ-Myc mice

Snail and serpinA1 promote tumor progression and predict prognosis in colorectal cancer

Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases

A novel oHSV-1 targeting telomerase reverse transcriptase-positive cancer cells via tumor-specific promoters regulating the expression of ICP4

PC-1/PrLZ confers resistance to rapamycin in prostate cancer cells through increased 4E-BP1 stability

Simultaneous inhibition of multiple oncogenic miRNAs by a multi-potent microRNA sponge

ROS1 amplification mediates resistance to gefitinib in glioblastoma cells

Mutated Fanconi anemia pathway in non-Fanconi anemia cancers

Upregulated long non-coding RNA AFAP1-AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinoma

The prognostic potential and oncogenic effects of PRR11 expression in hilar cholangiocarcinoma

Overexpression of microRNA-95-3p suppresses brain metastasis of lung adenocarcinoma through downregulation of cyclin D1

Epigenetically downregulated Semaphorin 3E contributes to gastric cancer

Highly sensitive and quantitative evaluation of the EGFR T790M mutation by nanofluidic digital PCR

Catalytic inhibitors of DNA topoisomerase II suppress the androgen receptor signaling and prostate cancer progression

CCL18-mediated down-regulation of miR98 and miR27b promotes breast cancer metastasis

Tumorigenesis and peritoneal colonization from fallopian tube epithelium

An increase in glucosylceramide synthase induces Bcl-xL-mediated cell survival in vinorelbine-resistant lung adenocarcinoma cells

Type II transglutaminase stimulates epidermal cancer stem cell epithelial-mesenchymal transition

Dragon (repulsive guidance molecule b, RGMb) is a novel gene that promotes colorectal cancer growth

Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma

Inhibition of RSK with the novel small-molecule inhibitor LJI308 overcomes chemoresistance by eliminating cancer stem cells

Acetylation at lysine 71 inactivates superoxide dismutase 1 and sensitizes cancer cells to genotoxic agents

Circulating and tumor-infiltrating Tim-3 in patients with colorectal cancer

The LPA1/ZEB1/miR-21-activation pathway regulates metastasis in basal breast cancer

Increased resistance to proteasome inhibitors in multiple myeloma mediated by cIAP2 - implications for a combinatorial treatment

Insulin-like growth factor binding protein 5 (IGFBP5) functions as a tumor suppressor in human melanoma cells

Mutation of N-linked glycosylation at Asn548 in CD133 decreases its ability to promote hepatoma cell growth

RNA sequencing reveals differentially expressed genes as potential diagnostic and prognostic indicators of gallbladder carcinoma

Identification of the interplay between SOX9 and S100P in the metastasis and invasion of colon carcinoma

CUEDC2 down-regulation is associated with tumor growth and poor prognosis in lung adenocarcinoma

AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis

SOX9, a potential tumor suppressor in cervical cancer, transactivates p21^WAF1/CIP1 and suppresses cervical tumor growth

Hypoxia promotes colon cancer dissemination through up-regulation of cell migration-inducing protein (CEMIP)